Min Pa: Min Pa(max): Activity's type:

Ext Pa Pi Pmax Activity Other Results ID Pa_max
0.9330.0010.933Ornithine decarboxylase inhibitor

0.88 0.001 DBMET01005

0.7740.0010.812Keratolytic

0.812 0.001 DBMET01005

DBMET01005
0.6520.0010.735Retinoic acid receptor agonist

0.735 0.001 DBMET01005

DBMET01005
0.5850.0010.678Retinoic acid alpha receptor agonist

0.678 0.001 DBMET01005

DBMET01005
0.5480.0010.684Retinoic acid beta receptor agonist

0.684 0.001 DBMET01005

DBMET01005
0.50.0040.521Glutamate (mGluR) antagonist

0.521 0.004 DBMET01005

DBMET01005
0.4960.0030.51Glutamate (mGluR group I) antagonist

0.51 0.003 DBMET01005

DBMET01005
0.4730.0050.543Glutamate receptor antagonist

0.543 0.004 DBMET01005

DBMET01005
0.4680.0010.549Retinoic acid gamma receptor agonist

0.549 0.001 DBMET01005

DBMET01005
0.4590.0030.48Glutamate (mGluR5) antagonist

0.48 0.003 DBMET01005

DBMET01005
0.40.0040.49Glutamate (mGluR) agonist

0.49 0.004 DBMET01005

DBMET01005
0.2850.0020.573Retinoic acid alpha receptor antagonist

0.573 0.001 DBMET01005

DBMET01005
0.2640.0050.333ABCA1 expression enhancer

0.333 0.005 DBMET01005

DBMET01005
0.2480.0020.568Retinoic acid receptor antagonist

0.568 0.001 DBMET01005

DBMET01005
0.3450.1110.422Analgesic

0.422 0.075 DBMET01005

DBMET01005
0.3570.1350.389Apoptosis agonist

0.389 0.119 DBMET01005

DBMET01005
0.2940.0980.294Calcium channel activator
0.2880.0980.288Vasodilator, coronary
0.2760.1070.276Cholesterol antagonist

0.254 0.122 DBMET01005

0.170.0020.449Retinoic acid receptor gamma antagonist

0.449 0.001 DBMET01005

DBMET01005
0.1670.0020.424Retinoic acid beta receptor antagonist

0.424 0.001 DBMET01005

DBMET01005
0.160.0090.16Calcium channel L-type blocker

0.075 0.045 DBMET01005

0.1840.0480.198Catenin beta inhibitor

0.198 0.034 DBMET01005

DBMET01005
0.2990.1660.3955 Hydroxytryptamine release inhibitor

0.395 0.081 DBMET01005

DBMET01005
0.1320.0030.16Retinoid X gamma receptor agonist

0.16 0.002 DBMET01005

DBMET01005
0.2920.1640.292Calcium channel L-type activator
0.2010.0820.201Anticonvulsant

0.143 0.138 DBMET01005

0.1140.0030.204Retinoid X beta receptor agonist

0.204 0.002 DBMET01005

DBMET01005
0.1080.0050.199Retinoid X alpha receptor agonist

0.199 0.002 DBMET01005

DBMET01005
0.1050.0040.146Retinoid X receptor agonist

0.146 0.003 DBMET01005

DBMET01005
0.1540.0550.154Calcium channel blocker
0.1390.0480.144Interleukin 1b antagonist

0.144 0.045 DBMET01005

DBMET01005
0.1010.0130.101Transcription factor AP-1 inhibitor
0.1670.080.167Tumour necrosis factor antagonist
0.1960.1160.202Hypoglycemic

0.202 0.11 DBMET01005

DBMET01005
0.1610.0850.1613C-like protease (Human coronavirus) inhibitor

0.149 0.103 DBMET01005

0.1560.0910.195Dual specificity phosphatase 3 inhibitor

0.195 0.064 DBMET01005

DBMET01005
0.1830.1190.183Vasodilator
0.080.0180.08Potassium channel intermediate-conductance Ca-activated blocker
0.0970.0390.275Glutamate receptor agonist

0.275 0.005 DBMET01005

DBMET01005
0.0940.0460.094Transcription factor NF kappa B stimulant

0.087 0.055 DBMET01005

0.1250.0820.125Interleukin 1 antagonist

0.109 0.106 DBMET01005

0.0640.0210.08Leukotriene C antagonist

0.08 0.008 DBMET01005

DBMET01005
0.0390.0050.047Retinoid X gamma receptor antagonist

0.047 0.003 DBMET01005

DBMET01005
0.1570.130.178Hypolipemic

0.178 0.111 DBMET01005

DBMET01005
0.1610.1350.161Cyclic AMP phosphodiesterase inhibitor
0.1640.140.164Tumour necrosis factor alpha release inhibitor
0.20.1760.2Vasodilator, peripheral
0.2110.1890.256Histamine release inhibitor

0.256 0.151 DBMET01005

DBMET01005
0.0460.0240.046GABA B receptor antagonist
0.2680.2480.391Antiinflammatory

0.391 0.145 DBMET01005

DBMET01005
0.0410.0220.056Leukotriene C4 antagonist

0.056 0.007 DBMET01005

DBMET01005
0.0780.0660.078Calcium antagonist
0.0460.0350.082Glutamate (mGluR group I) agonist

0.082 0.012 DBMET01005

DBMET01005
0.0970.0890.097Calcium channel (voltage-sensitive) blocker
0.0920.0870.092GABA receptor agonist
0.0280.0240.05Somatostatin 5 antagonist

0.05 0.013 DBMET01005

DBMET01005
0.0590.0570.076Leukotriene synthesis inhibitor

0.076 0.04 DBMET01005

DBMET01005
0.1190.1180.128NOS3 expression enhancer

0.128 0.101 DBMET01005

DBMET01005
0.0430.0430.045Baculoviral IAP repeat-containing protein inhibitor

0.045 0.036 DBMET01005

DBMET01005
0.0130.0190.019Free fatty acid receptor 1 agonist

0.019 0.011 DBMET01005

DBMET01005
0.0390.0450.063Glutamate (mGluR5) agonist

0.063 0.016 DBMET01005

DBMET01005
0.030.0370.045Farnesoid X receptor agonist

0.045 0.018 DBMET01005

DBMET01005
0.1230.1320.16Dual specificity phosphatase inhibitor

0.16 0.084 DBMET01005

DBMET01005
0.0290.0380.048Retinoid X alpha receptor antagonist

0.048 0.008 DBMET01005

DBMET01005
0.0310.0430.055Retinoid X receptor antagonist

0.055 0.009 DBMET01005

DBMET01005
0.0940.1070.13Cyclooxygenase 1 inhibitor

0.13 0.071 DBMET01005

DBMET01005
0.0460.0630.07DNA helicase inhibitor

0.07 0.017 DBMET01005

DBMET01005
0.1120.1310.127MAP3K9 inhibitor

0.127 0.1 DBMET01005

DBMET01005
0.0240.0490.054Nicotinic acid receptor 2 agonist

0.054 0.013 DBMET01005

DBMET01005
0.0150.0490.024Retinoid X beta receptor antagonist

0.024 0.008 DBMET01005

DBMET01005
0.0440.090.067DNA gyrase inhibitor

0.067 0.04 DBMET01005

DBMET01005
0.0170.0670.054Nicotinic acid receptor agonist

0.054 0.013 DBMET01005

DBMET01005
0.0410.0940.064Leukotriene antagonist

0.064 0.046 DBMET01005

DBMET01005
0.1080.2010.135CC chemokine 6 receptor antagonist

0.135 0.054 DBMET01005

DBMET01005
0.2160.3490.358Ca2+/calmodulin-dependent protein kinase kinase A inhibitor

0.358 0.142 DBMET01005

DBMET01005
0.0680.2160.12Protein-tyrosine phosphatase inhibitor

0.12 0.114 DBMET01005

DBMET01005
0.0370.1890.056Ryanodine receptor antagonist

0.056 0.051 DBMET01005

DBMET01005
0.1680.3270.288Cyclophilin D inhibitor

0.288 0.174 DBMET01005

DBMET01005
0.0310.2330.084Alcohol dehydrogenase inhibitor

0.084 0.073 DBMET01005

DBMET01005
Ext Pa Pi Pmax Activity Other Results ID Pa_max